• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

广泛的皮质变薄是伴有轻度认知障碍的 MS 患者的特征。

Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.

机构信息

Department of Neurosciences, University Hospital of Padova, Multiple Sclerosis Centre of Veneto Region, First Neurology Clinic, 35128 Padova, Italy.

出版信息

Neurology. 2010 Jan 26;74(4):321-8. doi: 10.1212/WNL.0b013e3181cbcd03.

DOI:10.1212/WNL.0b013e3181cbcd03
PMID:20101038
Abstract

BACKGROUND

Although cognitive dysfunction affects a relevant portion of patients with multiple sclerosis (MS), its pathologic substrate has not been clarified and it does not seem entirely explained by white matter changes.

METHODS

A total of 100 consecutive patients with relapsing remitting MS (RRMS) and 42 normal controls (NC) were enrolled in the study. Cognitive performance was assessed by Rao's Brief Repeatable Battery of Neuropsychological Tests (BRB). Regional cortical thickness (CTh) was evaluated by Freesurfer.

RESULTS

Thirty-one patients with RRMS failed 1 or 2 tests of BRB and were considered to have a mild cognitive impairment (mCI-RRMS), while 8 patients failed at least 3 tests and were classified as markedly impaired (sCI-RRMS). The mean CTh of mCI-RRMS and sCI-RRMS group was significantly lower than in NC (p < 0.001) and cognitively normal patients with RRMS (CN-RRMS) (p < 0.001). The regional analysis revealed significant cortical thinning in frontal and temporal regions (frontotemporal thinning) of CN-RRMS compared to NC, while a widespread pattern of cortical thinning was observed in mCI-RRMS and in sCI-RRMS compared to both CN-RRMS and NC. A correlation was observed between cognitive score (CS) and the mean CTh (r = -0.69, p < 0.001) and between CS and CTh of almost all the cortical areas analyzed (r value between -0.20 and -0.65, p < 0.01). A correlation was found between T2-WM-LV and mean CTh (r = -0.31, p = 0.004) or CS (r = 0.21, p = 0.031). The multivariate analysis confirmed a widespread cortical thinning as the best predictor of cognitive impairment.

CONCLUSIONS

A widespread pattern of cortical thinning characterizes patients with cognitive dysfunction, suggesting such dysfunction as expression of a more aggressive and widespread cortical pathology.

摘要

背景

尽管认知功能障碍影响了相当一部分多发性硬化症(MS)患者,但它的病理基础尚未阐明,而且似乎并不能完全用白质变化来解释。

方法

本研究共纳入 100 例复发缓解型多发性硬化症(RRMS)患者和 42 例正常对照者(NC)。采用 Rao 的简短可重复神经心理学测试电池(BRB)评估认知表现。采用 Freesurfer 评估皮质厚度(CTh)。

结果

31 例 RRMS 患者在 BRB 中出现 1 项或 2 项测试失败,被认为存在轻度认知障碍(mCI-RRMS),而 8 例患者至少有 3 项测试失败,被归类为明显受损(sCI-RRMS)。mCI-RRMS 和 sCI-RRMS 组的平均 CTh 明显低于 NC(p<0.001)和认知正常 RRMS 患者(CN-RRMS)(p<0.001)。区域分析显示,CN-RRMS 与 NC 相比,额叶和颞叶区域(额颞叶变薄)皮质变薄,而 mCI-RRMS 和 sCI-RRMS 与 CN-RRMS 和 NC 相比,皮质变薄呈广泛模式。认知评分(CS)与平均 CTh 之间存在相关性(r=-0.69,p<0.001),CS 与分析的几乎所有皮质区域的 CTh 之间也存在相关性(r 值在-0.20 至-0.65 之间,p<0.01)。T2-WM-LV 与平均 CTh(r=-0.31,p=0.004)或 CS(r=0.21,p=0.031)之间存在相关性。多元分析证实广泛的皮质变薄是认知障碍的最佳预测因素。

结论

广泛的皮质变薄模式是认知功能障碍患者的特征,表明这种功能障碍是更具侵袭性和广泛的皮质病理学的表现。

相似文献

1
Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.广泛的皮质变薄是伴有轻度认知障碍的 MS 患者的特征。
Neurology. 2010 Jan 26;74(4):321-8. doi: 10.1212/WNL.0b013e3181cbcd03.
2
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment.复发缓解型多发性硬化伴轻度认知障碍患者的新皮质体积减小
J Neurol Sci. 2006 Jun 15;245(1-2):195-9. doi: 10.1016/j.jns.2005.07.019. Epub 2006 Apr 24.
3
Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.个体认知概况对复发缓解型多发性硬化症视觉运动重组的影响。
Brain Res. 2007 Sep 5;1167:71-9. doi: 10.1016/j.brainres.2007.06.023. Epub 2007 Jun 21.
4
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.复发缓解型多发性硬化轻度残疾患者的认知障碍及其与疾病指标的关系:多发性硬化认知障碍(COGIMUS)研究的基线结果
Mult Scler. 2009 Jul;15(7):779-88. doi: 10.1177/1352458509105544.
5
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症中新皮质体积变化与认知功能恶化的关联。
Arch Neurol. 2007 Aug;64(8):1157-61. doi: 10.1001/archneur.64.8.1157.
6
APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.载脂蛋白 E-epsilon4 与复发缓解型多发性硬化症的认知障碍无关。
Mult Scler. 2009 Dec;15(12):1489-94. doi: 10.1177/1352458509348512. Epub 2009 Nov 13.
7
Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.脱失作为多发性硬化症认知功能障碍的一种机制。
Brain. 2009 Jan;132(Pt 1):239-49. doi: 10.1093/brain/awn275. Epub 2008 Oct 25.
8
A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.复发缓解型多发性硬化症皮质病变的 3 年磁共振成像研究。
Ann Neurol. 2010 Mar;67(3):376-83. doi: 10.1002/ana.21906.
9
Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.多发性硬化症患者小脑、皮质下及皮质萎缩的程度:一项病例对照研究。
J Neurol Sci. 2009 Jul 15;282(1-2):47-54. doi: 10.1016/j.jns.2008.12.034. Epub 2009 Feb 6.
10
Focal thinning of the cerebral cortex in multiple sclerosis.多发性硬化症中大脑皮质的局灶性变薄
Brain. 2003 Aug;126(Pt 8):1734-44. doi: 10.1093/brain/awg175. Epub 2003 Jun 4.

引用本文的文献

1
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study.早期脑区灰质损伤可预测多发性硬化症的长期认知障碍表型:一项20年的研究。
Brain Commun. 2024 Oct 12;6(6):fcae355. doi: 10.1093/braincomms/fcae355. eCollection 2024.
2
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage.CSF 帕伐丽珠蛋白水平在多发性硬化症诊断中可预测未来认知功能、身体残疾、疲劳和灰质损伤更差。
Neurol Neuroimmunol Neuroinflamm. 2024 Nov;11(6):e200301. doi: 10.1212/NXI.0000000000200301. Epub 2024 Aug 22.
3
The neural substrates of social cognition deficits in newly diagnosed multiple sclerosis patients.
新发多发性硬化症患者社会认知缺陷的神经基础。
Ann Clin Transl Neurol. 2024 Jul;11(7):1798-1808. doi: 10.1002/acn3.52085. Epub 2024 Jun 13.
4
Brain volume loss in Japanese patients with multiple sclerosis is present in the early to middle stage of the disease.日本多发性硬化症患者的脑容量损失出现在疾病的早期至中期。
Heliyon. 2024 Mar 18;10(6):e28136. doi: 10.1016/j.heliyon.2024.e28136. eCollection 2024 Mar 30.
5
Comparison of recent updates in genetics, immunology, biomarkers, and neuroimaging of primary-progressive and relapsing-remitting multiple sclerosis and the role of ocrelizumab in the management of their refractory cases.原发性进行性和复发缓解型多发性硬化症在遗传学、免疫学、生物标志物及神经影像学方面的最新进展比较以及奥瑞珠单抗在其难治性病例管理中的作用
Health Sci Rep. 2023 Jul 12;6(7):e1422. doi: 10.1002/hsr2.1422. eCollection 2023 Jul.
6
Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis.让不可见变为可见:自动测量的全脑和局部脑容量与多发性硬化症中的认知障碍和疲劳相关。
Bioengineering (Basel). 2022 Dec 29;10(1):41. doi: 10.3390/bioengineering10010041.
7
Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes.多发性硬化症中的症状关联性:对潜在基础生物学疾病过程的叙述性综述
Neurol Ther. 2022 Sep;11(3):1043-1070. doi: 10.1007/s40120-022-00368-2. Epub 2022 Jun 9.
8
Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosis.脑膜淋巴细胞的积累与进行性多发性硬化症的白质病变活动相关。
JCI Insight. 2022 Mar 8;7(5):e151683. doi: 10.1172/jci.insight.151683.
9
Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis.皮质厚度和血清 NfL 可解释多发性硬化症新诊断患者的认知功能障碍。
Neurol Neuroimmunol Neuroinflamm. 2021 Aug 31;8(6). doi: 10.1212/NXI.0000000000001074. Print 2021 Nov.
10
Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players.多发性硬化中的神经退行性变:沉默进展的症状、生物标志物和神经保护治疗——犬尿氨酸是重要的参与者。
Molecules. 2021 Jun 5;26(11):3423. doi: 10.3390/molecules26113423.